Genetic contributions to brain serotonin transporter levels in healthy adults

Genetic contributions to brain serotonin transporter levels in healthy adults

Abstract The serotonin transporter (5-HTT) critically shapes serotonin neurotransmission by regulating extracellular brain serotonin levels; it remains unclear to what extent 5-HTT levels in the human brain are genetically determined. Here we applied [11C]DASB positron emission tomography to image b...

Full description

Bibliographic Details
Main Authors:	Silvia Elisabetta Portis Bruzzone, Arafat Nasser, Sagar Sanjay Aripaka, Marie Spies, Brice Ozenne, Peter Steen Jensen, Gitte Moos Knudsen, Vibe Gedsoe Frokjaer, Patrick MacDonald Fisher
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-09-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-43690-x

Similar Items

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
by: Kristin Köhler-Forsberg, et al.
Published: (2020-07-01)

Effects of an Oral Contraceptive on Dynamic Brain States and Network Modularity in a Serial Single-Subject Study
by: Kristian Høj Reveles Jensen, et al.
Published: (2022-06-01)

No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study.
by: Dea Siggaard Stenbæk, et al.
Published: (2017-01-01)

Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals
by: Anjali Sankar, et al.
Published: (2023-05-01)

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
by: Vibeke Høyrup Dam, et al.
Published: (2022-11-01)

Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation
by: Daniel Rødbro Burmester, et al.
Published: (2023-02-01)

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study
by: Søren Vinther Larsen, et al.
Published: (2022-03-01)

Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
by: Anna Søndergaard, et al.
Published: (2022-10-01)

Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users
by: Emma Sofie Høgsted, et al.
Published: (2021-11-01)

Serotonin 4 receptor brain binding and oxytocin-promoted affective and social cognition in healthy women – A randomized controlled trial
by: Vibeke Høyrup Dam, et al.
Published: (2024-02-01)

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
by: Kristin Köhler-Forsberg, et al.
Published: (2022-07-01)

Functional brain responses to emotional faces after three to five weeks of intake of escitalopram in healthy individuals: a double-blind, placebo-controlled randomised study
by: Sophia Armand, et al.
Published: (2024-02-01)

Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression—a NeuroPharm study
by: Annika Læbo Rasmussen, et al.
Published: (2023-07-01)

Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort
by: Kristian Høj Reveles Jensen, et al.
Published: (2023-03-01)

Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disordersResearch in context
by: Anjali Sankar, et al.
Published: (2023-04-01)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
by: Olga B. Baltzersen, et al.
Published: (2020-04-01)

Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication
by: Juliane Conradi, et al.
Published: (2023-01-01)

Functional and molecular neuroimaging of menopause and hormone replacement therapy
by: Erika eComasco, et al.
Published: (2014-12-01)

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT<sub>2A</sub> Receptor Density in the Pig Brain
by: Nakul Ravi Raval, et al.
Published: (2021-01-01)

Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
by: Claus Thorn Ekstrøm, et al.
Published: (2022-10-01)

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder
by: Liv V. Hjordt, et al.
Published: (2020-06-01)

Brain Networks Implicated in Seasonal Affective Disorder: A Neuroimaging PET Study of the Serotonin Transporter
by: Martin Nørgaard, et al.
Published: (2017-11-01)

Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
by: Vincent Beliveau, et al.
Published: (2022-01-01)

Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression
by: Anders Jorgensen, et al.
Published: (2022-05-01)

Associations between the cortisol awakening response and patient-evaluated stress and mood instability in patients with bipolar disorder: an exploratory study
by: Maria Faurholt-Jepsen, et al.
Published: (2021-03-01)

Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects
by: Anders S. Olsen, et al.
Published: (2022-12-01)

Cognitive impairment and psychopathology in out-of-hospital cardiac arrest survivors in Denmark: The REVIVAL cohort study protocol
by: Jacob Eifer Moller, et al.
Published: (2020-09-01)

Psychometric Properties and Validation of the EMOTICOM Test Battery in a Healthy Danish Population
by: Vibeke H. Dam, et al.
Published: (2019-12-01)

High brain serotonin levels in migraine between attacks: A 5-HT4 receptor binding PET study
by: Marie Deen, et al.
Published: (2018-01-01)

Serotonin syndrome: A syndrome on syndrome
by: Sanjay Prakash, et al.
Published: (2021-01-01)

Serotonin transporter gene (SLC6A4) variation and sensory processing sensitivity—Comparison with other anxiety‐related temperamental dimensions
by: Cecilie L. Licht, et al.
Published: (2020-08-01)

Automated pupillometry to detect command following in neurological patients: a proof-of-concept study
by: Alexandra Vassilieva, et al.
Published: (2019-05-01)

Corelease and differential exit via the fusion pore of GABA, serotonin, and ATP from LDCV in rat pancreatic beta cells.
by: Braun, M, et al.
Published: (2007)

Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes
by: Skov Vibe, et al.
Published: (2012-02-01)

Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson’s Disease
by: Nakul Ravi Raval, et al.
Published: (2021-11-01)

An in vivo Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates
by: Nakul Ravi Raval, et al.
Published: (2022-03-01)

Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.
by: Vibe Skov, et al.
Published: (2008-06-01)

Mild serotonin syndrome: A report of 12 cases
by: Sanjay Prakash, et al.
Published: (2015-01-01)

Serotonin revisited.
by: Cowen, P, et al.
Published: (2011)

Secrets of serotonin /
by: 199195 Hart, Carol
Published: (1996)